Advertisement

Clinical Rheumatology

, 4:321 | Cite as

C-reactive protein levels in patients with rheumatoid arthritis: the impact of therapy

  • M. Tishler
  • D. Caspi
  • M. Yaron
Originals

Summary

C-reactive protein levels were measured in sera of 111 patients with rheumatoid arthritis and were compared with erythrocyte sedimentation rate. The patients were divided into six groups according to drug therapy. Comparison between the groups suggests that CRP correlates best with ESR in patients treated with penicillamine and in patients in clinical remission. Patients treated with gold, NSAID or methotrexate have a weaker correlation between the two parameters, while steroid therapy yields the poorest correlation which is not statistically significant. Our data suggest that although CRP is a sensitive index of disease activity, the specific drug taken by the patient must be considered before interpreting the results.

Key words

C-Reactive Protein Erythrocyte Sedimentation Rate Drug Treatment Rheumatoid Arthritis 

References

  1. 1.
    Tillet, W.S., Francis, T. Serological reaction in pneumonia with a non-protein somatic fraction of pneumococcus. J Exp Med 1930, 52, 561.CrossRefGoogle Scholar
  2. 2.
    Mallya, R.K., deBeer, F.C., Berry, H. et al. Correlation of clinical parameters of disease activity in rheumatoid arthritis with serum concentration of C-reactive protein and erythrocyte sedimentation rate. J Rheumatol, 1982, 9, 224–228.PubMedGoogle Scholar
  3. 3.
    Walsh, L., Davies, P., McConkey, B. Relationship between erythrocyte sedimentation rate and serum C-reactive protein in rheumatoid arthritis. Ann Rheum Dis, 1979, 38, 362–363.PubMedCrossRefGoogle Scholar
  4. 4.
    Dorohot, T.I., Niculescu, D., Rusu, G., Ponea, I. Serum and synovial fluid IgG, C3 and CRP levels in rheumatoid arthritis. Arch Roum Pathol Exp Microbiol, 1981, 40, 305–311.PubMedGoogle Scholar
  5. 5.
    American Rheumatism Association. Diagnostic criteria for rheumatoid arthritis. 1958 Revision. Ann Rheum Dis, 1959, 18, 49–53.CrossRefGoogle Scholar
  6. 6.
    Pepys, M.B. Aspects of acute phase response. The C-reactive protein system. In: Clinical Aspects of Immunology. Editor: Lachman, P.J., Peters, D.K. Blackwell Scientific Publications, Oxford, 1982, pp. 50–71.Google Scholar
  7. 7.
    Mallya, R.K., Vergani, D., Tee, D.E.H. et al. Correlation in rheumatoid arthritis of concentration of plasma C3d, serum rheumatoid factor, immune complexes and C-reactive protein with each other and with clinical features of disease activity. Clin Exp Immunol, 1982, 98, 747–753.Google Scholar
  8. 8.
    Pepys, M.B. Acute phase phenomena. In: The Science and Practice of Clinical Medicine, Rheumatology and Immunology. Editor: Cohen, A.S. Grune and Stratton, New York, 1979, 85–88.Google Scholar
  9. 9.
    Amos, R.S., Crockson, R.A., Crockson, A.P. et al. Rheumatoid arthritis: C-reactive protein and erythrocyte sedimentation rate during initial treatment. Br Med J, 1978, 1, 1396–1397.PubMedCrossRefGoogle Scholar
  10. 10.
    McConkey, B., Crockson, R.A., Crockson, A.P., et al. The effects of some anti-inflammatory drugs on the acute phase proteins in rheumatoid arthritis. Q J Med, 1973, 42, 785–791.PubMedGoogle Scholar
  11. 11.
    Constable, T.J., Crockson, R.A., Crockson, A.P. et al. Drug treatment of rheumatoid arthritis. Lancet, 1975, 1, 1176–117.CrossRefPubMedGoogle Scholar
  12. 12.
    Dixon, J.S., Bird, H.A., Sitton, N.G., et al. C-reactive protein in the serial assessment of disease activity in rheumatoid arthritis. Scand J Rheumatol, 1984, 13, 39–44.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 1985

Authors and Affiliations

  • M. Tishler
    • 1
    • 2
  • D. Caspi
    • 1
    • 2
  • M. Yaron
    • 1
    • 2
  1. 1.Department of RheumatologyIchilov HospitalTel AvivIsrael
  2. 2.Faculty of MedicineTel Aviv University SacklerTel AvivIsrael

Personalised recommendations